We describe the construction of a novel herpes simplex virus (HSV) vector containing a unique XbaI restriction enzyme cloning site in an intergenic position in the short unique genome region. Sequences can be inserted at this site with high efficiency by ligation with Xbaldigested vector DNA. A series of plasmids has been designed for use with this vector. These allow protein coding sequences to be placed under the control of various transcriptional regulation signals and then isolated as XbaI fragments ready for insertion into the vector. The XbaI fragments also contain the /~-galactosidase gene thereby facilitating selection of recombinant virus by screening for blue plaques. A variant of the vector has been made based on the temperature-sensitive (ts) mutant tsK, which expresses only immediate early (IE) genes at non-permissive temperatures. Chloramphenicol acetyltransferase was used as a reporter gene to assess the fidelity of expression of sequences cloned into this position. Under these circumstances IE and early HSV promoters were shown to behave as expected in both wild-type and ts vectors.
Introduction
Vector systems based on a wide variety of viruses have been developed which allow the expression of foreign genes to high levels in eukaryotic cells. Herpes simplex virus (HSV) possesses a number of characteristics which make it suitable as an expression vector. The large genome size allows the virus to accommodate additional DNA sequences without adversely affecting virus replication (Knipe et al., 1978) . Transcriptional regulation of HSV is well defined (reviewed in Everett, 1987) and transcriptionally limited mutants exist which presents opportunities for conditional expression of particular genes (Preston, 1979; Watson & Clements, 1980; Dixon & Schaffer, 1980) . HSV can infect a range of cell types in tissue culture and a variety of animal species, permitting use in various experimental situations. Furthermore, the existence of mutants affecting virus pathogenicity (Thompson et al., 1986; Taha et al., 1989) allows the creation of disabled vectors which establish self-limiting infections in experimental animals. HSV is a neurotropic virus capable of establishing long-term latent infections in sensory ganglia. Recent work has demonstrated limited transcription from latent virus genomes (Stevens et al., 1987) suggesting the potential for inducing stable expression in nervous tissue.
Previous studies have shown that foreign genes introduced into the HSV type 1 (HSV-1) genome can be expressed in infected cells (Shih et al., 1984; Smiley et al., 1987; Palella et al., 1988; Panning & Smiley, 1989) . The usual method for inserting such genes has been through recombination into a non-essential HSV-1 gene. Typically, the thymidine kinase (TK) locus has been used and recombinants selected on the basis of TK-phenotypes. A different strategy has been described for pseudorabies virus, in which recombination is performed in vitro using the Cre-lox recombination system (Sauer et al., 1987) . This is an efficient process which results in up to 5% recombinant progeny and also allows foreign DNA sequences to be inserted at a position of choice. Plasmidbased defective viruses have also been used as cloning vehicles (Geller & Breakefield, 1988) and in these systems, wild-type or mutant HSV is required as a helper to allow replication of the defective genomes. Consequently, such vectors are mixtures of defective and helper virus.
In this paper we describe a system whereby DNA fragments can be inserted by direct ligation into an HSV-1 genome which has been modified to contain a unique XbaI site. Ligation of XbaI-digested vector DNA with DNA fragments which have compatible termini generates recombinant virus at a high frequency. A temperature-sensitive (ts) variant of the virus vector has been constructed which allows conditional expression of inserted sequences. A series of plasmids which express flgalactosidase has been constructed for use in this system, thereby allowing viruses containing exogenous sequences to be identified by screening for blue plaques. 0000-9657 © 1990 SGM F. J. Rixon and J. McLauchlan The plasmids used in this study also contain the chloramphenicol acetyltransferase (CAT) gene under the control of two viral promoters. Induction of CAT by recombinant viruses has been examined in order to assess the fidelity of expression from the virus vectors.
Methods

Virus and cells.
All experiments were performed in BHK C13 cells cultured in Glasgow modified Eagle's medium containing 10% calf serum (ETC10). The parental virus was 1702, a variant of HSV-1 strain 17 + from which the four naturally occurring XbaI sites had been removed (MacLean & Brown, 1987) . Previously, 1702 had been designated X4 (MacLean & Brown, 1987) .
Preparation ofvirion DNA. Virions were prepared from monolayers of BHK C13 cells grown on 80oz. roller bottles using the procedure described in Rixon et al. (1988) . DNA was extracted from virions by treatment with SDS and phenol (Stow & Wilkie, 1976) and precipitated by addition of 2 volumes of ethanol. Purified DNA, digested to completion with Xbal, was divided into aliquots and stored at -20 °C.
Construction and screening of recombinant virus. Plasmid DNAs cleaved with XbaI were electrophoresed on agarose gels from which the appropriate fragments were isolated and purified. These fragments were ligated with XbaI-digested virus DNA prior to transfection onto monolayers of BHK cells. Transfections were performed using the calcium phosphate precipitation/DMSO method described by Stow & Wilkie (1976) . Digested vector DNA (0.51xg) was used in each transfection. Following transfection the cells were either overlaid directly with Eagle's medium without phenol red, which contained 0.5 % agar (agar medium) or were overlaid with ETC 10 for subsequent harvesting and titration of progeny virus. Titrations were performed under agar medium. Two days after transfection or infection, a further 2 ml of agar medium containing 0.75 mg/ml X-gal was added to each plate. After incubation overnight, plaques expressing fl-galactosidase were picked. All viruses were purified to homogeneity typically through three to four rounds of plaque purification. Their structures were analysed by restriction enzyme digestion of 32p-labelled virus DNA (Lonsdale, 1979) .
CAT assays. BHK cells were infected at an m.o.i, of 10 p.f.u./cell with the appropriate virus. At various times after infection, the cells were harvested and washed with phosphate-buffered saline and resuspended in 250 mM-Tris-HCl pH 8.0. Cells were frozen and thawed three times and cell debris was removed by centrifugation. Extracts were assayed for CAT activity using the solvent extraction procedure of Seed & Sheen (1988) and protein concentrations were determined by Bradford assays (Bradford, 1976 Polyacrylaraide gel electrophoresis and Western blot analysis. Cells were infected at an m.o.i, of 10 p.f.u./cell in Glasgow modified Eagle's medium containing 2 % calf serum and a fifth the normal concentration of methionine. Two h after infection, 50 p.Ci of [35S]methionine was added and incubation was continued at 37 °C for a further 14 h. Samples were prepared and gel electrophoresis was performed as described previously (Marsden et al., 1978) . For Western blot analysis (Towbin et al., 1979) , proteins were electrophoresed on 9 to 18% polyacrylamide gels and thereafter transferred to a nitrocellulose membrane. The nitrocellulose membrane was incubated with anti-CAT antibody (supplied by 5 Prime-3 Prime Inc.) at a dilution of 1/200 for 2 h at 37 °C. Bound antibody was detected by reaction with ~2sI-labelled Protein A.
Plasmid construction and modification. All restriction enzymes were used according to supplier's instructions. Oligonucleotides containing the multiple cloning sites were synthesized using a Biosearch 8600 Oligonucleotide Synthesizer.
XbaI linkers were inserted into the PvulI site in pCH 110 and the RsaI site in pGX40 following incomplete digestion in the presence of ethidium bromide (Shortle & Botstein, 1983) and isolation of linearized DNA from agarose gels. The HindlII site in pFJ5 was removed by incomplete digestion with HindlII, isolation of linearized DNA, treatment with T4 DNA polymerase to remove single-stranded 5' termini and religation.
Results
Strategy for construction of an HSV-1 DNA vector
The aim of this work was to generate an HSV-1 genome containing a unique restriction enzyme site into which appropriate DNA fragments could be inserted (Fig. 1 a) . The strategy was to introduce a unique XbaI site into the genome of the XbaI site-deficient virus, 1702 (MacLean & Brown, 1987) at a position which would not inactivate any virus gene function. The XbaI site was inserted between Us genes 8/9 and 10/11/12 which are encoded by convergently transcribed transcripts and whose mRNA 3' termini are separated by some 400 bp of DNA (Fig. l b; . This intergenic region contains a tandemly reiterated 15 bp nucleotide sequence which is not conserved in the equivalent region of HSV-2 DNA (J. L. Whitton, personal communication) and is therefore unlikely to be of functional importance.
Introduction of a unique XbaI site into the Us region of HSV-1 DNA (i) Construction of plasmids expressing the fl-galactosidase gene
In all subsequent experiments the Escherichia coli flgalactosidase gene was used as a marker gene to facilitate identification of recombinant virus. The parental plasmid used to express fl-galactosidase was pCHll0 (supplied by Pharmacia LKB Biotechnology) which contains the lacZ gene flanked by the simian virus 40 (SV40) early promoter and early poly(A) site sequences (Hall et al., 1983) . To adapt pCHll0 for use with the HSV-1 vector, an XbaI linker was inserted into the PvuII site upstream from the SV40 promoter to generate plasmid pFJ 1 ( Fig. 2 and see Methods). A second XbaI site was introduced downstream from the SV40 polyadenylation signals by inserting an oligonucleotide containing multiple restriction site sequences into the unique BamHI site of pFJ1, thus generating pFJ3 (Fig. 2). 
GGGTG~C~GAGTC, GGTC~TC~GAGTGGGTGGGTGGGGAGTGGGTGGGTGGGGAG TGGGTGGGTGGGGAG~G~G~GAG~GG~GG~GGGAG The T-terminal portions of genes US8/9 and US10/ll/12 map within BamHI z which is present in plasmid pGX40 . The RsaI site which lies in the intergenic region (Fig. 1 b) was converted to an XbaI site by introduction of a linker (see Methods) to give plasmid pGX40Xba. The XbaI fragment from pFJ3 carrying the/3-galactosidase gene was inserted into the XbaI site in pGX40Xba generating pGX40Gal, pGX40Gal DNA was digested with PstI (which cuts within the pAT153 vector sequences) and transfected into BHK cells along with 1702 viral DNA. Progeny virus was titrated and plaques expressing flgalactosidase were selected. The frequency of putative recombinant progeny was < 10 -3. The presence of a novel XbaI fragment within BamHI z, which spans the US8/9-US10/I 1/12 intergenic region, was confirmed by restriction enzyme analysis of 32p-labelled DNA from individual virus isolates purified to homogeneity (data not shown). DNA from one recombinant virus was purified, digested to completion with XbaI and, follow- ing religation, was transfected onto cell monolayers. Progeny virus was titrated and overlaid with agar containing X-gal. Colourless plaques were selected and one isolate (designated 1801) was purified to homogeneity. The original XbaI-deficient virus, 1702, had a thymidine kinase-negative (TK-) phenotype and thus 1801 was also TK-. The TK ÷ phenotype was rescued following cotransfection of 1801 DNA with linearized pTK1 plasmid, which contains the sequences encoding the TK gene (Preston & McGeoch, 1981) . A stock of TK ÷ virus (designated 1802) was prepared following plaque purification. Restriction enzyme analysis of 1802 and 1702 confirmed that 1802 contained a unique XbaI site in BamHI z (Fig. 3, compare lanes 3 and 4) . Furthermore, the insertion of this XbaI site had not resulted in any other marked changes from the 1702 pattern; only those fragments which are known to show intra-strain variability differed between the 1702 and 1802 profiles. HSV DNA exists as four equimolar forms due to inversion of the short and long genome segments (Hayward et al., 1975; Delius & Clements, 1976) . Therefore, the fragments produced by XbaI digestion of 1802 arise from all four isomeric forms. As ligations were performed with unseparated fragments, all possible (Davison et al., 1984) . At the non-permissive temperature (38.5 °C), tsK-infected cells overproduce IE gene products but fail to express early or late gene products (Preston, 1979; Watson & Clements, 1980) . To extend the potential of the virus vector system the tsK mutation was inserted into 1802 virus DNA. Linearized pGX13 DNA, which contains the tsK mutation (Davison et al., 1984) , and 1802 viral DNA were cotransfected into BHK cells. Following the selection of individual plaques, virus isolates which failed to grow at 38.5 °C were purifed to homogeneity and one isolate, 1803, was selected for use in subsequent experiments; complementation analysis confirmed that 1803 contained a lesion in IE3 (data not shown). We assume that 1803 contains the tsK mutation but have not directly demonstrated this by DNA sequencing.
Efficiency of cloning in 1802 DNA
To examine the efficiency with which non-homologous DNA fragments could be inserted into 1802 DNA, XbaIdigested 1802 DNA was ligated with increasing amounts of the XbaI fragment from pFJ3 which contains the flgalactosidase gene ( Fig. 2 and Table 1 ). From the resultant transfection, two plates of cells from each sample were overlaid directly with agar medium and exposed to X-gal to determine the proportion of primary plaques expressing fl-galactosidase. Two remaining plates from each sample were overlaid with ETC10 and incubated until complete c.p.e, was apparent. The progeny virus from these plates was titrated to determine the proportion of recombinant virus. Table 1 shows that the proportion of primary plaques expressing fl-galactosidase increased with increasing relative amounts of pFJ3 DNA. The total number of plaques also increased slightly which is somewhat surprising, given that a large molar excess of pFJ3 might be expected to interfere with correct ligation of the viral genomic fragments. The proportion of primary plaques expressing fl-galactosidase was very high (69~) under conditions of highest molar excess of pFJ3. By contrast, examination of the virus from plate harvests indicated that a smaller proportion of secondary plaques expressed fl-galactosidase, reaching a maximum of 23 ~. If one assumes that the virus expressing fl-galactosidase is at no selective disadvantage, then this would reflect the proportion of recombinant genomes in the ligation. In other experiments using different DNA fragments, all progeny plaques often appeared blue; however, individually selected plaques frequently segregated into blue and clear types suggesting that many of the plaques contained a mixed population of both recombinant and wildtype progeny.
Construction of e.xpression plasmids
A BamHI fragment from plasmid pTER5 , which contains the sequences encoding the CAT protein linked to poly(A) site sequences from the HSV-2 IE5 gene, was inserted into the BamHI site of pFJ3, generating pFJ5. The structure of pFJ5 is designed such that promoter sequences of interest can be inserted into unique restriction enzyme sites upstream from the CAT gene (Fig. 2) . Digestion of these plasmids with XbaI gives a DNA fragment which contains the CAT and lacZ genes and this fragment can then be ligated into virus vector DNA. The CAT coding region in pFJ5 and all its derivatives can be removed by HindlII digestion and replaced with sequences encoding other proteins. A third HindlII site, present in the SV40/lacZ sequences of pCH110, was removed from pFJ5 (see Methods) and the resultant plasmid designated pFJ5AHind (Fig. 2) . The behaviour of viral promoters from both the IE (HSV-2 IE4/5) and early [HSV-2 ribonucleotide reductase subunit 2 (RR2)] temporal classes was examined in the vector system. The HSV-2 IE4/5 promoter was isolated as a 400 bp BamHI fragment from plasmid pLW51 which carries both IE activator and promoter sequences, pLW51 is a derivative of pLW5 (Gaffney et F. J. Rixon and J. McLauchlan xbal~F'~2~fq[~7 3000 5o00" ~ 5000 -'--a 4000 4000 Fig. 4 . Construction of CAT expression plasmids, pFJ7 was generated by insertion of a 550 bp BgllI/BamHI fragment containing the HSV-2 RR2 promoter into the BgllI site of pFJ5AH/nd. To make pFJl0, a 400 bp fragment containing the HSV-2 IE4/5 promoter was inserted into the BgllI site of pFJ5AHind. P1, SV40 early promoter; T1, SV40 early polyadenylation sequences; P2, HSV-2 promoter; T2, HSV-2 IE5 polyadenylation sequences; lac, fl-galactosidase coding sequences; CAT, chloramphenicol acetyltransferase coding sequences. al., 1985) in which the BamHI site between the activator and promoter sequences has been removed and the HindlII site upstream from the activator sequences converted to a BamHI site. The 400 bp fragment was inserted into the BgllI site of pFJ5AHind to generate pFJ10 (Fig. 4) . The HSV-2 RR2 promoter was isolated as a 550 bp BgllI/BamHI fragment from a plasmid carrying HSV-2 BamHI e (McLauchlan & Clements, 1983) and was inserted into the BgllI site of pFJ5AHind to generate pFJ7 (Fig. 4) .
The appropriate XbaI fragments from pFJ7 and pFJ10 were introduced into both 1802 and 1803 DNA. The resultant viruses were designated vFJ7 and vFJ7tsK, vFJ10 and vFJ10tsK. High titre stocks of each virus were prepared for use in subsequent experiments.
CA T expression from recombinant viruses
The levels of CAT activity produced by vFJ7 and vFJ10 were determined at various times after infection at 31 °C and 38.5 °C; a typical set of data is shown in Fig. 5 (a) . vFJ7 and vFJ 10 showed similar patterns of induction. At 38.5 °C, CAT activity was detected by 3 h post-infection, showed a marked increase between 3 h and 6 h and continued to rise until the latest time examined, 12 h. At 31 °C, the time course of induction was considerably slower. The activities by 12 h at 31 °C were similar to those after 6 h at 38.5 °C and this reflects the slower rate of virus replication at 31 °C.
CAT activities were also examined in cells infected with vFJ7tsK and vFJ10tsK at permissive (31 °C) and non-permissive (38.5°C) temperatures (Fig. 5b) . At 31 °C, the induction of CAT activities was similar to those ofvFJ7 and vFJ10. At 38.5 °C, vFJ10tsK showed a rapid and continuous rise in CAT activity, reaching levels only slightly below those produced by vFJ10 by 12 h post-infection. This correlates with the behaviour of IE promoters during tsK infection. By contrast, vFJ7tsK induced extremely low levels of CAT activity at all times, reflecting the behaviour expected for an early promoter in tsK at 38.5 °C. Thus, the IE and RR2 promoters used in these experiments behave as would be predicted in both the wild-type and tsK virus vectors.
To examine directly the accumulation of CAT protein during infection, polypeptide profiles of vFJ7 and vFJ 10 were examined. Both vFJ7 and vFJ10 profiles had bands of the approximate size expected for CAT protein (Fig.  6a, lanes 4 and 5; Shaw, 1975) , which were not present in the control samples; however, these bands do not comigrate. Western blot analysis using anti-CAT antibody confirmed them as CAT protein (Fig. 6b and c) . The reason for the size difference of CAT protein produced by the two viruses is that the promoter used in vFJ7 contains an inframe ATG which introduces 17 extra amino acids at the N terminus of CAT. Interestingly, the amount of the Mr 21000 protein (21 K) synthesized by vFJ7 and vFJ10 is reduced compared to the control samples (Fig. 6a, the unique XbaI site in 1802 (Rixon & McGeoch, 1984) and the reduction in the amount of 21K protein could be the result of read-through transcription from the inserted sequences in vFJ7 and vFJ10.
Discussion
The vector system described in this paper provides a simple and reproducible method for introducing specific DNA sequences into a defined location in the HSV-1 genome. The high efficiency with which viruses containing inserted sequences can be recovered and the ability to screen visually for fl-galactosidase activity makes isolation of recombinant viruses straightforward. In addition, the plasmids constructed for use with the virus vector increase the versatility of the system by facilitating interchange of transcriptional control regions and coding sequences. In this study we have used different promoters to drive CAT gene expression in vFJ7 and vFJ10, but protein-coding and mRNA 3' processing sequences can also be manipulated. Analysis of a CAT gene cassette, containing tandemly arranged poly(A) sites, inserted into 1802 has already facilitated identification of an HSV-induced factor which alters poly(A) site usage (McLauchlan et al., 1989) . It is also relatively easy to construct alternative expression plasmids to use with these vectors. For example, J. Bates and C. Langford (personal communication) have constructed a plasmid containing the human cytomegalovirus major IE promoter which they have used to clone and express genes from Leishmania major and Plasmodium falciparum in 1802. While the plasmids we have constructed increase the flexibility of the vector, any restriction enzyme fragment with compatible termini can be inserted into the XbaI site of 1802 or 1803 DNA. We have shown that temporal control of expression is retained when using the IE promoter in vFJ10 and vFJ 10tsK and the early promoter in vFJ7 and vFJ7tsK. Thus, the RR2 and IE4/5 promoters appear to behave normally irrespective of their position in the genome. The pattern of CAT activity induction exhibited by vFJ7 closely resembled the pattern of RR2 mRNA synthesis in HSV-2-infected cells (McLauchlan, 1986) . In this case therefore, CAT activity appears to provide an accurate indication of promoter activity. It may appear anomalous that CAT activity in vFJ10, which is under control of an IE promoter, closely mirrored that for the early promoter construct in vFJ7 since repression of IE gene expression at later stages of infection has been reported F. J. Rixon and J. McLauchlan (DeLuca & Schaffer, 1985; O'Hare & Hayward, 1985) . However, in agreement with our findings, other groups have shown that IE mRNAs continue to accumulate throughout lytic infection and that translational controls may be involved in regulating expression of IE proteins (Harris-Hamilton & Bachenheimer, 1985; Weinheimer & McKnight, 1987) . Clearly, the HSV-2 IE4/5 promoter is functional in vFJ10tsK-infected cells and produces high levels of CAT activity. Thus, use of this promoter in 1803 allows conditional expression of inserted sequences in the absence of synthesis of most other (i.e. early and late) HSV-encoded genes.
In order to reduce the possibility of interfering with the expression of endogenous virus genes, the cloning site was placed in an intergenic region in Us. Interestingly, expression of the 21K (US11) protein, a member of a gene family (Fig. 1 b) which lies adjacent to the sequences inserted at the XbaI site, was markedly reduced in cells infected with vFJ7 and vFJ10 compared with control viruses. The common 3' terminus of the US10/ll/12 transcripts lies approximately 160 bp from the XbaI site in 1802 DNA. This reduction is unlikely to be a direct effect of the introduced sequences on mRNA processing since the signals required for efficient 3' end formation are contained within 40 to 50 bp beyond the poly(A) site of HSV mRNAs Zhang et al., 1986) . One possibility is that transcriptional readthrough from the inserted sequences in vFJ7 and vFJl0 could lower the amount of USll mRNA available for translation either by production of anti-sense mRNA or transcriptional interference. Recently, it has been shown that readthrough of the HSV-2 IE5 poly(A) site sequences inserted into the virus vector occurs during lytic infection (McLauchlan et al., 1989) . Thus, inefficient processing at the poly(A) sites of the CAT and flgalactosidase genes present in vFJ7 and vFJ10 could produce transcripts complementary to USll mRNA. Indirect evidence for this effect is that high levels of IE transcription markedly reduce fl-galactosidase activity in vFJ10tsK-infected cells at 38-5 °C compared with the activity in vFJ7tsK-infected cells where little transcription is detected from the RR2 promoter (data not shown). At present, we are examining whether there is a similar reduction in expression of the other genes which flank the inserted sequences. Transcriptional readthrough could alter the abundance of a number of virus products and we are currently investigating the extent to which this mechanism influences HSV gene expression.
The transcriptional control sequences in pFJ7 and pFJ10 were derived from HSV-2 DNA. No rearrangements have been detected between the inserted sequences and the equivalent endogenous regions in the HSV-1 genome in any of our recombinant viruses. The HSV-2 DNA sequences do share homology with HSV-1 (McLauchlan & Clements, 1983; Whitton & Clements, 1984 ) but presumably they are sufficiently different to prevent rearrangement occurring by recombination. We have inserted up to 6 kbp of foreign DNA into the virus vector without detectably altering the genome. The maximum capacity of the HSV-1 genome is not known although DNA fragments up to 10kbp have been inserted into a pseudorabies virus vector (Sauer et al., 1987) . Given the high efficiency of recovery of virus recombinants with this system, the fl-galactosidase marker gene could be dispensed with in situations where the size of insert would be potentially limiting.
In conclusion, we have developed a novel HSV vector system which can be readily adapted for a number of uses. Moreover, the levels of expression from inserted sequences are comparable to those of endogenous viral proteins. At present, we have not attempted to modify this vector system to maximize levels of expression; however, work in progress has shown that CAT activity can be significantly increased using alternative transcription control signals.
